UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of 15(R)-15-methyl prostaglandin E2 (arbaprostil) on the healing of duodenal ulcer: a double-blind multicenter study

Gastroenterology (New York, N.Y. 1943), 1982-08, Vol.83 (2), p.357-363

1982

Volltextzugriff (PDF)

Prevention of acute aspirin-induced gastric mucosal injury by 15-R-15 methyl prostaglandin E2: An endoscopic study

Gastroenterology (New York, N.Y. 1943), 1984-02, Vol.86 (2), p.339-345

1984

Volltextzugriff (PDF)

Arbaprostil [15(R)-15-methyl prostaglandin E2] in a single nighttime dose of either 50 or 100 micrograms in acute duodenal ulcer

Gastroenterology (New York, N.Y. 1943), 1989-07, Vol.97 (1), p.98-103

1989

Volltextzugriff (PDF)

Failure of a cytoprotective dose of arbaprostil to heal acute duodenal ulcers: results of a multiclinic trial

Gastroenterology (New York, N.Y. 1943), 1987-03, Vol.92 (3), p.604-607

1987

Volltextzugriff (PDF)

A report of three multiclinic trials evaluating arbaprostil in arthritic patients with ASA/NSAID gastric mucosal damage. The Upjohn Company Arbaprostil ASA/NSAID Gastric Mucosal Damage Treatment Study Groups

Gastroenterology (New York, N.Y. 1943), 1990-06, Vol.98 (6), p.1549

1990

Volltextzugriff (PDF)

Therapy of peptic ulcer with cytoprotective substances

Wiener medizinische Wochenschrift, 1983, Vol.133 (4-5), p.94-98

Fortunat, W

1983

Volltextzugriff (PDF)

Damage and protection of the human gastric mucosa: A multiparameter assessment

The American journal of medicine, 1988-02, Vol.84 (2), p.35-40

Hogan, Daniel L.

1988

Volltextzugriff (PDF)

Cytoprotective doses of arbacet with minimal antisecretory properties are not effective in duodenal ulcer healing

Digestive diseases and sciences, 1987-08, Vol.32 (8), p.857-860

1987

Volltextzugriff (PDF)

Failure of a cytoprotective dose of arbacet to heal acute gastric ulcers

The American journal of gastroenterology, 1988-07, Vol.83 (7), p.734-736

1988

Volltextzugriff (PDF)

The influence of 15(R)-15 methyl PGE2, methyl ester, on Nd:YAG laser-induced gastric ulcers

Gastrointestinal endoscopy, 1984-06, Vol.30 (3), p.173-178

1984

Volltextzugriff (PDF)

Treatment of hemorrhagic gastritis with 15(R)-15 methyl prostaglandin E2: report of a case

Gastroenterology (New York, N.Y. 1943), 1982-03, Vol.82 (3), p.558-560

1982

Volltextzugriff (PDF)

A multiclinic trial evaluating arbaprostil [15(R)-15-methyl prostaglandin E2] as a therapeutic agent for gastric ulcer

Gastroenterology (New York, N.Y. 1943), 1989-04, Vol.96 (4), p.967-971

1989

Volltextzugriff (PDF)

Prostanoids cytoprotection for maintaining remission in ulcerative colitis. Failure of 15(R), 15-methylprostaglandin E2

Digestive diseases and sciences, 1983-09, Vol.28 (9), p.807-811

1983

Volltextzugriff (PDF)

The effect of 15(R)-15-methyl prostaglandin E2 (arbacet) on the healing of aspirin or nonsteroidal antiinflammatory drug-induced gastric mucosal lesions: an endoscopic study

The American journal of gastroenterology, 1987-12, Vol.82 (12), p.1271-1274

1987

Volltextzugriff (PDF)

Modulation of inflammatory reactions by prostaglandins

Progress in lipid research, 1981, Vol.20, p.633-640

1981

Volltextzugriff (PDF)

Recent developments in synergistic drugs for protective factors in peptic ulcer--clinical efficacy and problems; prostaglandins

Nihon rinshō, 1988-01, Vol.46 (1), p.64

1988

Volltextzugriff (PDF)

Prostaglandin therapy in a case of refractory stress ulcer bleeding

Critical care medicine, 1982-07, Vol.10 (7), p.486-487

1982

Volltextzugriff (PDF)

Effect of prostaglandin E2 and 15(R)15 methyl PGE2 on duodenal ulcer

Singapore medical journal, 1980-06, Vol.21 (3), p.596-598

1980

Volltextzugriff (PDF)

Controlled trial of arbaprostil in bleeding peptic ulcer

BMJ, 1985-10, Vol.291 (6502), p.1093-1093

1985

Volltextzugriff (PDF)

Controlled trial of arbaprostil in bleeding peptic ulcer

BMJ, 1985-11, Vol.291 (6505), p.1351-1351

1985

Volltextzugriff (PDF)

Effect of treatment with 15/R/15-methyl derivative of prostaglandin E2 on aspirin- and indomethacin-induced damage of the mucous membrane of the upper digestive tract in rheumatoid arthritis patients

Polski tygodnik lekarski (Warsaw, Poland : 1960), 1987-09, Vol.42 (38), p.1183

1987

Volltextzugriff (PDF)

A therapeutic trial of 15 (R)-15-methyl prostaglandin E2 in rheumatoid arthritis patients with gastroduodenal lesions

Prostaglandins, 1981, Vol.21 Suppl, p.165-173

1981

Volltextzugriff (PDF)

Effectiveness and Renal Functions Safety of Treatments Used for Neonates with Patent Ductus Arteriosus: A Prospective Cohort Study

Medical science monitor, 2019-05, Vol.25, p.3668-3675

2019

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(23)

Sprache

Erscheinungsjahr

n.n

Thema

Arbaprostil - Therapeutic Use
(22)
Humans
(21)
Prostaglandins E, Synthetic - Therapeutic Use
(20)
Life Sciences & Biomedicine
(14)
Male
(14)
Science & Technology
(14)
Female
(12)
Adult
(11)
Double-Blind Method
(10)
Clinical Trials As Topic
(9)
Gastroenterology & Hepatology
(9)
Middle Aged
(9)
Aged
(8)
Arbaprostil - Administration & Dosage
(7)
Biological And Medical Sciences
(7)
Digestive System
(7)
Medical Sciences
(7)
Pharmacology. Drug Treatments
(7)
Gastric Mucosa - Drug Effects
(6)
Duodenal Ulcer - Drug Therapy
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effect of 15(R)-15-methyl prostaglandin E2 (arbaprostil) on the healing of duodenal ulcer: a double-blind multicenter study

Prevention of acute aspirin-induced gastric mucosal injury by 15-R-15 methyl prostaglandin E2: An endoscopic study

Arbaprostil [15(R)-15-methyl prostaglandin E2] in a single nighttime dose of either 50 or 100 micrograms in acute duodenal ulcer

Failure of a cytoprotective dose of arbaprostil to heal acute duodenal ulcers: results of a multiclinic trial

A report of three multiclinic trials evaluating arbaprostil in arthritic patients with ASA/NSAID gastric mucosal damage. The Upjohn Company Arbaprostil ASA/NSAID Gastric Mucosal Damage Treatment Study Groups

Therapy of peptic ulcer with cytoprotective substances

Damage and protection of the human gastric mucosa: A multiparameter assessment

Cytoprotective doses of arbacet with minimal antisecretory properties are not effective in duodenal ulcer healing

Failure of a cytoprotective dose of arbacet to heal acute gastric ulcers

The influence of 15(R)-15 methyl PGE2, methyl ester, on Nd:YAG laser-induced gastric ulcers

Treatment of hemorrhagic gastritis with 15(R)-15 methyl prostaglandin E2: report of a case

A multiclinic trial evaluating arbaprostil [15(R)-15-methyl prostaglandin E2] as a therapeutic agent for gastric ulcer

Prostanoids cytoprotection for maintaining remission in ulcerative colitis. Failure of 15(R), 15-methylprostaglandin E2

The effect of 15(R)-15-methyl prostaglandin E2 (arbacet) on the healing of aspirin or nonsteroidal antiinflammatory drug-induced gastric mucosal lesions: an endoscopic study

Modulation of inflammatory reactions by prostaglandins

Recent developments in synergistic drugs for protective factors in peptic ulcer--clinical efficacy and problems; prostaglandins

Prostaglandin therapy in a case of refractory stress ulcer bleeding

Effect of prostaglandin E2 and 15(R)15 methyl PGE2 on duodenal ulcer

Controlled trial of arbaprostil in bleeding peptic ulcer

Controlled trial of arbaprostil in bleeding peptic ulcer

Effect of treatment with 15/R/15-methyl derivative of prostaglandin E2 on aspirin- and indomethacin-induced damage of the mucous membrane of the upper digestive tract in rheumatoid arthritis patients

A therapeutic trial of 15 (R)-15-methyl prostaglandin E2 in rheumatoid arthritis patients with gastroduodenal lesions

Effectiveness and Renal Functions Safety of Treatments Used for Neonates with Patent Ductus Arteriosus: A Prospective Cohort Study

Suchergebnisse filtern